| Trade Names | |
| Synonyms | |
| Status | |
| Molecule Category | Free-form |
| ATC | J05AE05 |
| UNII | 5S0W860XNR |
| InChI Key | YMARZQAQMVYCKC-OEMFJLHTSA-N |
|---|---|
| Smiles | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C25H35N3O6S |
| Molecular Weight | 505.64 |
| AlogP | 2.4 |
| Hydrogen Bond Acceptor | 7.0 |
| Hydrogen Bond Donor | 3.0 |
| Number of Rotational Bond | 11.0 |
| Polar Surface Area | 131.19 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 35.0 |
| Mechanism of Action | Action | Reference |
|---|---|---|
| Human immunodeficiency virus type 1 protease inhibitor | INHIBITOR | FDA |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Cytochrome P450
Cytochrome P450 family 3
Cytochrome P450 family 3A
Cytochrome P450 3A4
|
- | - | - | 260-370 | - | |
|
Enzyme
Cytochrome P450
Cytochrome P450 family 3
Cytochrome P450 family 3A
Cytochrome P450 3A5
|
- | - | - | 200 | - | |
|
Enzyme
Protease
Aspartic protease
Aspartic protease AA clan
Aspartic protease A2A subfamily
|
- | 1-440 | 1.1 | 0.03-225 | - | |
|
Enzyme
Protease
Cysteine protease
Cysteine protease PAC clan
Cysteine protease C3A subfamily
|
- | - | - | 0.007-600 | - | |
|
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC21/SLCO family of organic anion transporting polypeptides
|
- | - | - | - | -3.4-79.3 |
| Resources | Reference |
|---|---|
| ChEBI | 40050 |
| ChEMBL | CHEMBL116 |
| DrugBank | DB00701 |
| DrugCentral | 200 |
| FDA SRS | 5S0W860XNR |
| Human Metabolome Database | HMDB0014839 |
| KEGG | C08086 |
| PDB | 478 |
| PharmGKB | PA448422 |
| PubChem | 65016 |
| SureChEMBL | SCHEMBL34151 |
| ZINC | ZINC000003809192 |